ɪn tˈuː θˈaʊzənd nˈaɪntiːn, ðə ɹˈeɪnwɔːɾɚ tʃˈæɹɪɾəbəl ɐwˈɔːɹdᵻd ɪts tˈuː fˈɜːst pɹˈaɪzᵻz: wˈʌn fɔːɹ aʊtstˈændɪŋ ˌɪnəvˈeɪʃən ɪn nˈʊɹɹoʊddʒˌɛnɚɹətˌɪv dɪzˈiːz ɹᵻsˈɜːtʃ tə dˈɑːktɚ. mˈɪtʃəl ɡˈoʊdɚt ˌɛmˌɑːɹsˈiː, kˈeɪmbɹɪdʒ, jˌuːkˈeɪ ænd wˈʌn fɔːɹ ˈɪnəvˌeɪɾɪv ˈɜːlɪkɚɹˈɪɹ sˈaɪəntɪst tə dˈɑːktɚ. pˈætɹɪk ˌeɪtʃˌɛsjˈuː jˈuːnɪv. kˌælɪfˈoːɹniə, bˈɜːkli, jˌuːˌɛsˈeɪ.
In 2019, the Rainwater Charitable awarded its two first prizes: one for outstanding innovation in neurodegenerative disease research to Dr. Michel Goedert (MRC, Cambridge, UK) and one for innovative early-career scientist to Dr. Patrick Hsu (Univ. California, Berkeley, USA).